AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimigen-M1 Tablet

Prescription Icon
Prescription Required

Marketer

Ekard Life Sciences Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimigen-M1 Tablet

Diabetol Duo tablets are classified as antidiabetic medications. This dual-drug formulation treats type 2 diabetes in adults by regulating blood glucose. Diabetol Duo should be taken with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may adjust based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan, including diet, exercise, and weight management as directed by your doctor; lifestyle significantly influences diabetes control. Hypoglycemia (low blood sugar) is a common side effect; learn to recognize symptoms like sweating, dizziness, headache, and tremors, and know how to counteract them with fast-acting glucose sources (e.g., sugary snacks, juice). Alcohol increases hypoglycemia risk and should be avoided. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. Diabetol Duo is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe liver or kidney disease. Prior heart conditions should be disclosed to your physician before initiating treatment. Consult your doctor before use during pregnancy or breastfeeding. Regular blood glucose monitoring and periodic blood tests (to assess blood cell counts and liver function) are recommended.

Primary Ingredients of Glimigen-M1 Tablet

No text was provided to rewrite.

Uses of Glimigen-M1 Tablet

Managing type 2 diabetes

Major Benefits of Glimigen-M1 Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimigen-M1 Tablet whole; avoid chewing, crushing, or breaking it. Administer this medicine with food.

Common Side effects of Glimigen-M1 Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimigen-M1 Tablet:

Consume this medication precisely as prescribed by your physician, adhering to the recommended dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glimigen-M1 Tablets should be administered with a meal.

How Glimigen-M1 Tablet works:

Glimepiride and Metformin, the active components of Glimigen-M1 Tablet, synergistically manage blood sugar. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, reducing blood glucose. Metformin, a biguanide, acts through multiple mechanisms: decreasing hepatic glucose output, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Glimigen-M1 Tablets is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimigen-M1 Tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to any prescription. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Lactation and Glimigen-M1 tablets are incompatible. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimigen-M1 Tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Glimigen-M1 Tablet use. Physician consultation is necessary. Routine kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimigen-M1 Tablets cautiously, potentially requiring dosage modification. Medical advice is necessary. For those with mild to moderate liver disease, a low initial dose is typically prescribed; however, Glimigen-M1 Tablets are contraindicated in cases of severe hepatic dysfunction.

What if you forget to take Glimigen-M1 Tablet :

Should you forget a Glimigen-M1 Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimigen-M1 Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimigen-M1 Tablet

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimigen-M1 Tablets can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glimigen-M1 and seek immediate medical attention.
Glimigen-M1 Tablet combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. It enhances blood glucose control when used with a healthy diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. This combination is unsuitable for type 1 DM.
Glimigen-M1 Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged Glimigen-M1 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Glimigen-M1 Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Glimigen-M1 tablets and alcohol is unsafe. This combination can dangerously lower blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glimigen-M1 Tablet
36
MRP 44
18% off